JP2004520398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004520398A5 JP2004520398A5 JP2002563926A JP2002563926A JP2004520398A5 JP 2004520398 A5 JP2004520398 A5 JP 2004520398A5 JP 2002563926 A JP2002563926 A JP 2002563926A JP 2002563926 A JP2002563926 A JP 2002563926A JP 2004520398 A5 JP2004520398 A5 JP 2004520398A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26255501P | 2001-01-18 | 2001-01-18 | |
PCT/US2002/000497 WO2002064132A2 (en) | 2001-01-18 | 2002-01-14 | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004520398A JP2004520398A (en) | 2004-07-08 |
JP2004520398A5 true JP2004520398A5 (en) | 2005-12-22 |
Family
ID=22998000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002563926A Pending JP2004520398A (en) | 2001-01-18 | 2002-01-14 | Paclitaxel chemotherapy microemulsion composition with improved oral bioavailability |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1365759A2 (en) |
JP (1) | JP2004520398A (en) |
AR (1) | AR032642A1 (en) |
CA (1) | CA2434641A1 (en) |
MX (1) | MXPA03006404A (en) |
NZ (1) | NZ539046A (en) |
PE (1) | PE20020833A1 (en) |
WO (1) | WO2002064132A2 (en) |
ZA (1) | ZA200305086B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6750246B1 (en) | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
FR2838349B1 (en) * | 2002-04-15 | 2004-06-25 | Laurence Paris | LIQUID COMPOSITIONS FOR SUSTAINED RELEASE SOFT CAPSULES AND PROCESS FOR PRODUCING THE SAME |
KR100533458B1 (en) | 2002-07-20 | 2005-12-07 | 대화제약 주식회사 | Composition for solubilization of paclitaxel and preparation method thereof |
EP1498120A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Semi-solid formulations for the oral administration of taxoids |
EP1498143A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
US20050123602A1 (en) * | 2003-09-25 | 2005-06-09 | Michaelis Arthur F. | Rifalazil formulations |
CA2611592A1 (en) * | 2005-06-17 | 2006-12-21 | Hospira Australia Pty Ltd | Liquid pharmaceutical formulations of docetaxel |
EP3594248B1 (en) * | 2006-10-27 | 2021-08-04 | Capsugel Belgium NV | Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
US20090088393A1 (en) * | 2007-09-28 | 2009-04-02 | Zomanex, Llc | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
KR101053780B1 (en) * | 2008-02-29 | 2011-08-02 | 동아제약주식회사 | Single liquid stable pharmaceutical composition containing docetaxel |
JP5868414B2 (en) * | 2010-11-08 | 2016-02-24 | カディラ ファーマシューティカルズ リミテッド | Taxoid pharmaceutical composition |
CN103110581B (en) * | 2013-02-26 | 2015-07-22 | 西南大学 | Taxol microemulsion drug composition and preparation method thereof |
KR101542364B1 (en) * | 2014-10-31 | 2015-08-07 | 대화제약 주식회사 | Pharmaceutical composition for oral administration comprising taxanes |
ES2895948T3 (en) * | 2015-07-30 | 2022-02-23 | Dae Hwa Pharma Co Ltd | Pharmaceutical composition for oral administration comprising taxane at high concentration |
CN107028931A (en) | 2016-02-04 | 2017-08-11 | 上海宣泰医药科技有限公司 | A kind of taxol drug composition and its pharmaceutical preparation, preparation method and purposes |
EP3701943A1 (en) * | 2019-02-26 | 2020-09-02 | CAPNOMED GmbH | Delayed delivery of anticancer drugs |
WO2023220109A1 (en) * | 2022-05-11 | 2023-11-16 | Eli Lilly And Company | Glp1 pharmaceutical compositions |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998053811A1 (en) * | 1997-05-27 | 1998-12-03 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
WO1998013359A1 (en) * | 1996-09-24 | 1998-04-02 | Marigen S.A. | Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect |
CH688504A5 (en) * | 1997-03-26 | 1997-10-31 | Marigen Sa | Spontaneously dispersible concentrate containing a taxol analogue |
IL133585A0 (en) * | 1997-06-20 | 2001-04-30 | Baker Norton Pharma | Soluble prodrugs of paclitaxel |
IL131217A0 (en) * | 1998-03-10 | 2001-01-28 | Napro Biotherapeutics Inc | Novel methods and compositions for delivery of taxanes |
US6638522B1 (en) * | 1998-12-11 | 2003-10-28 | Pharmasolutions, Inc. | Microemulsion concentrate composition of cyclosporin |
AU768022B2 (en) * | 1999-05-27 | 2003-11-27 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
US6919370B2 (en) * | 2000-11-28 | 2005-07-19 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
-
2002
- 2002-01-14 WO PCT/US2002/000497 patent/WO2002064132A2/en not_active Application Discontinuation
- 2002-01-14 JP JP2002563926A patent/JP2004520398A/en active Pending
- 2002-01-14 NZ NZ539046A patent/NZ539046A/en unknown
- 2002-01-14 CA CA002434641A patent/CA2434641A1/en not_active Abandoned
- 2002-01-14 MX MXPA03006404A patent/MXPA03006404A/en unknown
- 2002-01-14 EP EP02718808A patent/EP1365759A2/en not_active Withdrawn
- 2002-01-17 AR ARP020100158A patent/AR032642A1/en unknown
- 2002-01-17 PE PE2002000030A patent/PE20020833A1/en not_active Application Discontinuation
-
2003
- 2003-06-30 ZA ZA200305086A patent/ZA200305086B/en unknown